Sep 18, 2019
Dr. Ralph Kern, Chief Medical Officer, BrainStorm Cell Therapeutics talks about their late stage clinical programs in treating ALS and MS using stem cells derived from bone marrow as well as the promise of using their technology platform to manufacture the cells to develop therapies for other neurodegenerative diseases...
Sep 18, 2019
Dr. Ralph Kern, Chief Medical Officer, BrainStorm Cell Therapeutics talks about their late stage clinical programs in treating ALS and MS using stem cells derived from bone marrow as well as the promise of using their technology platform to manufacture the cells to develop therapies for other neurodegenerative diseases...
Aug 12, 2019
Dr. Costas Hadjipanayis, Director of Neurosurgical Oncology for Mount Sinai Beth Israel Hospital discusses his experience working with the advanced robotically-controlled digital microscope, Modus V, from Synaptive Medical and how this technology was used recently to successfully remove a 19-year old woman's rare brain...
Aug 12, 2019
Dr. Costas Hadjipanayis, Director of Neurosurgical Oncology for Mount Sinai Beth Israel Hospital discusses his experience working with the advanced robotically-controlled digital microscope, Modus V, from Synaptive Medical and how this technology was used recently to successfully remove a 19-year old woman's rare brain...
Mar 8, 2017
Ed Boyden PhD, Associate Professor, Media Lab and McGovern Institute, Massachusetts Institute of Technology is exploring how light can be used to treat neurological diseases using non-invasive devices and genetic engineering. He talks about the emerging field of neurotechnology, bringing together problem experts and...